๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Zenapax and effect on clinical outcome of hepatitis C post liver transplant

โœ Scribed by Islam, Khondker K.; Rustgi, Vinod K.; Kuo, Paul C.; Plotkin, Jeffrey S.; Kim, Kyung; Johnson, Lynt B.


Book ID
122387124
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
177 KB
Volume
118
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Histological and clinical outcome after
โœ M C Shuhart; M P Bronner; D R Gretch; L V Thomassen; C F Wartelle; H Tateyama; S ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 189 KB ๐Ÿ‘ 1 views

Hepatitis frequently recurs after liver transplantation for early recurrence is associated with a higher risk of disease progression. (HEPATOLOGY 1997;26:1646-1652.) hepatitis C. However, the histological progression of disease, predictors of recurrence and disease severity, and patient survival rem

Clinical and virologic outcomes of hepat
โœ Makoto Taniguchi; A. Obaid Shakil; Hugo E. Vargas; Tomasz Laskus; Anthony J. Dem ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 57 KB ๐Ÿ‘ 1 views

Hepatitis B (HBV) and C viral (HCV) dual-infectionassociated liver disease is an uncommon indication for liver transplantation. The clinical and virologic outcomes in such patients have not been well studied. We retrospectively studied 13 patients with hepatitis B surface antigen (HBsAg) and antibod